Aardvark Therapeutics, Inc. (AARD)
NASDAQ: AARD · Real-Time Price · USD
4.570
-2.160 (-32.10%)
At close: May 15, 2026, 4:00 PM EDT
4.520
-0.050 (-1.09%)
After-hours: May 15, 2026, 7:58 PM EDT
Aardvark Therapeutics Employees
Aardvark Therapeutics had 40 employees as of March 31, 2026. The number of employees increased by 14 or 53.85% compared to the same quarter last year.
Employees
40
Change
14
Growth
53.85%
Revenue / Employee
n/a
Profits / Employee
-$1,746,725
Market Cap
99.70M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Mar 31, 2026 | 40 | 14 | 53.85% | 40 | 0 |
| Dec 31, 2025 | 40 | 18 | 81.82% | 40 | 0 |
| Sep 30, 2025 | 33 | 15 | 83.33% | 33 | 0 |
| Jun 30, 2025 | 31 | 17 | 121.43% | 31 | 0 |
| Mar 31, 2025 | 26 | 12 | 85.71% | 26 | 0 |
| Dec 31, 2024 | 22 | - | - | 22 | 0 |
| Sep 30, 2024 | 18 | - | - | 17 | 1 |
| Jun 30, 2024 | 14 | - | - | 12 | 2 |
Related Stocks
| Company Name | Employees |
|---|---|
| Cibus | 118 |
| Inovio Pharmaceuticals | 112 |
| Verrica Pharmaceuticals | 76 |
| Rani Therapeutics Holdings | 71 |
| PepGen | 56 |
| Vivani Medical | 42 |
| Oncolytics Biotech | 29 |
| Q32 Bio | 24 |
AARD News
- 17 hours ago - Aardvark Therapeutics downgraded to Underperform from Buy at BofA - TheFly
- 22 hours ago - Aardvark Therapeutics price target lowered to $7 from $8 at B. Riley - TheFly
- 22 hours ago - Aardvark Therapeutics Inc trading halted, volatility trading pause - TheFly
- 22 hours ago - Aardvark Therapeutics Inc trading resumes - TheFly
- 23 hours ago - Aardvark Therapeutics downgraded to Neutral from Buy at BTIG - TheFly
- 1 day ago - Aardvark downgraded to Underweight from Equal Weight at Morgan Stanley - TheFly
- 1 day ago - Aardvark Therapeutics announces FDA clinical hold on ARD-101 - TheFly
- 1 day ago - FDA places full clinical hold on Aardvark's drug for extreme hunger in Prader-Willi syndrome - Reuters